Cargando…
Economics of drug‐coated balloons for arteriovenous fistula stenosis in Japan and Korea based on the IN.PACT AV access trial
AIM: The recent IN.PACT AV Access study found drug‐coated balloon therapy to be associated with reduced reinterventions compared to percutaneous transluminal angioplasty using standard balloons in the management of arteriovenous fistula stenosis. The economic implications of drug‐coated balloon use...
Autores principales: | Chun, Ho Jong, Cao, Khoa N., Haruguchi, Hiroaki, Choi, Hyunsook, Yoshikawa, Mayuko, Holden, Andrew, Pietzsch, Jan B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons Australia, Ltd
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9826040/ https://www.ncbi.nlm.nih.gov/pubmed/36068700 http://dx.doi.org/10.1111/nep.14085 |
Ejemplares similares
-
IN.PACT SFA Clinical Study Using the IN.PACT Admiral Drug-Coated Balloon in a Chinese Patient Population
por: Chen, Zhong, et al.
Publicado: (2019) -
IN.PACT™ Admiral™ drug-coated balloons in peripheral artery disease: current perspectives
por: Torii, Sho, et al.
Publicado: (2019) -
Three-Year Results of the IN.PACT SFA Japan Trial Comparing Drug-Coated Balloons With Percutaneous Transluminal Angioplasty
por: Soga, Yoshimitsu, et al.
Publicado: (2020) -
Long-Term Outcomes of the 150 mm Drug-Coated Balloon Cohort from the IN.PACT Global Study
por: Brodmann, Marianne, et al.
Publicado: (2022) -
Long‐term outcomes after paclitaxel‐coated balloon angioplasty of femoropopliteal arteries in Asian patients of the IN.PACT Global Study
por: Ko, Young‐Guk, et al.
Publicado: (2022)